Moderna climbs for second straight session

Alpha Pro Tech

11/05/2026 14:49

Updates

** Shares of Moderna MRNA.O rise 5.4% to $57.27

** The stock logged its biggest weekly jump since mid-January on Friday

** Last week, the vaccine maker told Reuters it conducted preclinical research on hantaviruses in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases

** Shares of DNA medicines developer Inovio INO.O jump 11.6%, vaccine maker Novavax NVAX.O gain 3.6%

** Investors may see potential for INO's DNA medicines platform in hantavirus vaccine development, says Stephens analyst Sudan Loganathan

** In 2011, INO received a federal grant to study DNA vaccine delivery for emerging infectious disease and pandemic preparedness

** Shares of personal protective equipment makers Lakeland Industries LAKE.O rise 3.4% and Alpha Pro Tech APT.A jump about 12%

** Up to last close, MRNA up 84.3% YTD

 (Reporting by Christy Santhosh)

 ((Christy.Santhosh@thomsonreuters.com))